Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

Saved in:
Bibliographic Details
Main Authors: Loibl, Sibylle (Author) , Schneeweiss, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: Annals of oncology
Year: 2016, Volume: 28, Issue: 3, Pages: 497-504
ISSN:1569-8041
DOI:10.1093/annonc/mdw610
Online Access:Verlag, Volltext: https://doi.org/10.1093/annonc/mdw610
Get full text
Author Notes:S. Loibl, C. Jackisch, A. Schneeweiss, S. Schmatloch, B. Aktas,C. Denkert, H. Wiebringhaus, S. Kümmel, M. Warm, S. Paepke, M. Just, C. Hanusch, J. Hackmann, J.-U. Blohmer, M. Clemens, S. Dan Costa, B. Gerber, K. Engels, V. Nekljudova, G. von Minckwitz, M. Untch on behalf of the investigators of the German Breast Group (GBG) and the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast (AGO-B) study groups
Description
Item Description:Published online: 10 November 2016
Gesehen am 12.04.2018
Physical Description:Online Resource
ISSN:1569-8041
DOI:10.1093/annonc/mdw610